Skip to main content
FinSpry Logo
FinSpry
BDSX logo
BDSX
(NASDAQ)
Biodesix, Inc.
$15.07-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Biodesix (BDSX) Stock Price & Financial Analysis

Biodesix Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$14.51 - $15.49
52-Week High$20.21
52-Week Low$3.44
Open$14.73
Volume40.54K
Average Volume (3M)40.54K
Market Cap121.54M
Shares Outstanding8.06M
Price to Sales (P/S)1.35
EV/EBITDA-7.86
Revenue (TTM)88.50M
Net Income (TTM)-35.27M
Free Cash Flow (TTM)-23.72M
EPS (TTM)$-4.37
Profit Margin-39.85%
Operating Margin-31.38%
50-Day MA$13.67
200-Day MA$8.95
52-Week Change21.76%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Biodesix

What is the current stock price for BDSX?

As of the latest trading session, BDSX stock trades at $15.07. The 52-week range is $3.44–$20.21, with a day range of $14.51–$15.49.

What is the P/E ratio for BDSX?

The P/E ratio (Price-to-Earnings) for BDSX is shown in the Key Statistics section. This valuation metric helps compare Biodesix, Inc. to industry peers.

Does BDSX pay dividends?

Biodesix does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BDSX?

Based on 2 analysts, the consensus for BDSX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BDSX?

Biodesix's market capitalization is $121.5M, classifying it as a micro-cap company. Biodesix operates in the Healthcare sector within the Diagnostics & Research industry.